UG Healthcare logo

41A - UG Healthcare Share Price

S$2.79 -0.2  -6.7%

Last Trade - 9:50am

Small Cap
Market Cap £327.9m
Enterprise Value £349.1m
Revenue £57.9m
Position in Universe 1469th / 5989
Unlock 41A Revenue
Relative Strength (%)
1m +67.1%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
49.0 55.7 58.8 65.2 78.1 91.7 125.9 164.2 +13.4%
+30.4 -36.1 +47.1 -56.0 +77.3 -42.5 +247 +211.1
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 31 December 2019, UG Healthcare Corporation Ltd revenues increased 28% to SP$53.2M. Net income decreased 36% to SP$846K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Other income decrease of 90% to SP$132K (income), Administrative expenses increase of 20% to SP$6.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 41A
Graphical History


41A Revenue Unlock 41A Revenue

Net Income

41A Net Income Unlock 41A Revenue

Normalised EPS

41A Normalised EPS Unlock 41A Revenue

PE Ratio Range

41A PE Ratio Range Unlock 41A Revenue

Dividend Yield Range

41A Dividend Yield Range Unlock 41A Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
41A EPS Forecasts Unlock 41A Revenue
Profile Summary

UG Healthcare Corporation Limited is a Malaysia-based manufacturer and distributor of natural latex and nitrile examination gloves. The Company operates through two business divisions, Manufacturing and Distribution. The Company manufactures and offers its examination glove products under its own brand name, Unigloves, as well as third-party labels. It also distributes ancillary products that include surgical, vinyl and cleanroom gloves, face masks and other medical disposables. Its products are sold to over 50 countries, including Germany, the People's Republic of China (PRC), the United States, the United Kingdom, France, Italy, South Korea, Japan, Canada, Nigeria and Brazil. The Company has a distribution network through its own distribution companies based in the United States, the United Kingdom, Germany, the PRC, Brazil and Nigeria, as well as through third-party distributors. The Company has two manufacturing facilities located in Seremban, Malaysia.

Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated August 21, 2014
Public Since December 8, 2014
No. of Shareholders: 513
No. of Employees: 628
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Singapore Exchange Securities Trading Ltd
Shares in Issue 196,092,856
Free Float (0.0%)
Eligible for
41A Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 41A
Upcoming Events for 41A
Wednesday 23rd September, 2020 Estimate
UG Healthcare Corporation Ltd Annual Shareholders Meeting
Frequently Asked Questions for UG Healthcare
What is the UG Healthcare share price?

As of 9:50am, shares in UG Healthcare are trading at S$2.79, giving the company a market capitalisation of £327.9m. This share price information is delayed by 15 minutes.

How has the UG Healthcare share price performed this year?

Shares in UG Healthcare are currently trading at S$2.79 and the price has moved by 1.66k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the UG Healthcare price has moved by 1.55k% over the past year.

What are the analyst and broker recommendations for UG Healthcare?

Of the analysts with advisory recommendations for UG Healthcare, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for UG Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will UG Healthcare next release its financial results?

UG Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the UG Healthcare dividend yield?

UG Healthcare does not currently pay a dividend.

Does UG Healthcare pay a dividend?

UG Healthcare does not currently pay a dividend.

When does UG Healthcare next pay dividends?

UG Healthcare does not currently pay a dividend.

How do I buy UG Healthcare shares?

To buy shares in UG Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of UG Healthcare?

Shares in UG Healthcare are currently trading at S$2.79, giving the company a market capitalisation of £327.9m.

Where are UG Healthcare shares listed? Where are UG Healthcare shares listed?

Here are the trading details for UG Healthcare:

Country of listing: Singapore
Exchange: SES
Ticker Symbol: 41A
What kind of share is UG Healthcare?

Based on an overall assessment of its quality, value and momentum, UG Healthcare is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a UG Healthcare share price forecast 2020?

Shares in UG Healthcare are currently priced at S$2.79. At that level they are trading at 44.31% premium to the analyst consensus target price of 0.00.

Analysts covering UG Healthcare currently have a consensus Earnings Per Share (EPS) forecast of 0.045 for the next financial year.

How can I tell whether the UG Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UG Healthcare. Over the past six months, the relative strength of its shares against the market has been 1.16k%. At the current price of S$2.79, shares in UG Healthcare are trading at 0.436k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the UG Healthcare PE Ratio?

The UG Healthcare PE ratio based on its reported earnings over the past 12 months is 0.269k. The shares are currently trading at S$2.79.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of UG Healthcare?

UG Healthcare's management team is headed by:

Wah Pung Yip - NEC
Keck Keong Lee - CEO
Lee Jun Yih - EDR
See Keong Wong - EDR
Jun Linn Lee - EDR
Teck Chai Lim - IND
Lip Chi Ng - IND
Pek Wee Wong - OTH
Beng Chee Ang - OTH
Jun Yih Lee - FID
Vincent Leow - NID
Who are the major shareholders of UG Healthcare?

Here are the top five shareholders of UG Healthcare based on the size of their shareholding:

Zen UG Pte. Ltd. Corporation
Percentage owned: 49.68% (97.4m shares)
Raydion Direct Global Inc Corporation
Percentage owned: 13.48% (26.4m shares)
Wong (See Keong) Individual Investor
Percentage owned: 4.9% (9.61m shares)
Lee (Sheng Poh Jeremy) Individual Investor
Percentage owned: 4.1% (8.04m shares)
Ang (Beng Teck) Individual Investor
Percentage owned: 2.76% (5.42m shares)
Similar to 41A
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.